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Paratesticular rhabdomyosarcoma (RMS) occurs more frequently in children and is rare in adults.
Embryonal RMS is the most common subtype of paratesticular RMS. Spindle cell is a rare variant of
embryonal RMS and is associated with a favorable prognosis in children. Data in adults is lacking. We
present a case of paratesticular RMS in a 24-year-old man.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Case Presentation
A 24-year-old healthy man presented with a painless right
scrotal mass for 3 weeks. He denied any difﬁculty with urination,
dysuria, or hematuria. He denied any history of recent trauma,
sexually transmitted diseases, or erectile dysfunction. His exami-
nation was signiﬁcant for a nontender mobile epididymal mass
measuring approximately 1 cm. He had no hernias. An ultraso-
nography examination revealed a small right epididymal tail mass
with questionable vascularity. Bilateral testicles were otherwise
normal. Given a low suspicion for malignancy, the patient was
placed on surveillance. He returned for follow-up 3 months later,
and the mass was found to be enlarged. A repeat ultrasonography
demonstrated an enlarged right epididymal tail lesion with 2 new
additional masses measuring up to 3 cm. These lesions were
hypervascular and the testicles were without masses. Tumor
markers were normal, and a computed tomography scan did not
suggest any lymphadenopathy or metastatic lesions.
The patient elected to undergo right epididymal exploration via
an inguinal approach and was consented for possible radical or-
chiectomy. On exploration, the masses were limited to the epidid-
ymal head. The diagnosis on frozen section was inconclusive,
revealing a predominantly spindle cell neoplasm. The differential
diagnosis included a sarcoma. The decision was made to preserve
the testis and the remainder of the cord. The surgery wasBY-NC-ND license (http://
: þ1-305-674-2899.
.
Published by Elsevier Inc. All righuncomplicated. The ﬁnal pathologic diagnosis was a paratesticular
embryonal rhabdomyosarcoma, spindle cell type (Fig. 1A,B; Fig. 2).
Immunohistochemical staining was positive for myogenin and
desmin, indicating skeletal muscle differentiation (Fig. 1C,D).
Staining was negative for Human Melanoma Black-45, smooth
muscle actin, and S-100. Margins of resection were negative for
malignancy.
Given his diagnosis of clinical T1N0M0 paratesticular rhabdo-
myosarcoma, spindle cell type, the patient was seen by a medical
oncologist who recommended radical inguinal orchiectomy with
ipsilateral nerve-sparing lymph node dissection followed by
chemotherapy. The patient declined further surgery and was initi-
ated on chemotherapy.Discussion
Tumors in the paratesticular region are rare. They typically
present as a rapidly growing and painless intrascrotal mass, elic-
iting only anatomically associated symptoms. Ultrasonography is
the diagnostic imaging modality of choice.1 The lesion is typically
hypoechoic and may demonstrate increased vascularity on
Doppler ultrasonography. The mass may be associated with a hy-
drocele, which may lead to a diagnosis of epididymitis rather than
malignancy.1 Most commonly found in the paratesticular region
are benign solid masses (ie, adenomatoid tumors, leiomyomas)
and cysts (ie, epididymal cysts, spermatocele). Adenomatoid tu-
mors are round well-deﬁned masses with variable echogenicity
that do not demonstrate increased vascularity. Leiomyomas are
solid and hypoechoic or heterogeneous masses that may have
calciﬁcation.ts reserved.
Figure 1. (A,B) Heterogeneous cellular proliferation including spindle and strap-like cells with rhabdomyoblastic differentiation (arrow). (C) Tumor cells strongly positive for
desmin. (D) Tumor cells showing nuclear expression of myogenin.
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are malignant.2 Sarcomas are the most common malignant neo-
plasms in the paratesticular area, and rhabdomyosarcomas (RMSs)
represent 24% of adult sarcoma cases.2 Of these RMS, 7%-10%
involve the paratesticular region.3
Paratesticular RMS include several subtypes, namely embryonal,
alveolar, and pleomorphic.4 Most cases are of embryonal histology.
Spindle cell type is a rare variant of embryonal RMS, and was ﬁrst
documented in 1992 by Cavazzana.5 Adult spindle cell cases ac-
count for 3% of all RMSs.6 Notably, only a few case reports exist
which describe a paratesticular lesion in an adult.
Gross dissection has often shown a white or tan whorled
appearance occasionally accompanied by necrosis or cystic degen-
eration.4 Microscopically, spindle cell RMS often displays fascicular
elongated cells with central nuclei and eosinophilic ﬁbrillary
cytoplasm with a small proportion of rhabdomyoblasts, featuring
more eccentric nuclei, striations, and sharper eosinophilia. Inter-
spersed collagen ﬁbers have also been noted. The utility of frozen
section to deﬁnitively diagnose these lesions is difﬁcult as was
noted in this case. Histologically, spindle cell rhabdomyosarcoma
may be considered in stains positive for desmin and is virtually
conﬁrmed (speciﬁcity close to 100% and sensitivity w95%) whenFigure 2. (A) Multinodular epididymal mass. (B) Threepositive for myogenin and MyoD1d2 transcription factors involved
in rhabdomyogenesis.4
Given a dearth of evidence and cases, treatment modalities have
not been differentiated from those of other paratesticular RMSs.4 A
diagnosis of paratesticular RMS of any variant typically warrants
initial treatment with radical inguinal orchiectomy followed by
systemic chemotherapy.7 Patients aged>10 years have been shown
to have a higher risk of lymph node involvement.8,9 Dang9 reported
that retroperitoneal lymph node dissection in these patients led to
an improved 5-year survival from 64% to 86%. Radiation therapy for
positive lymph nodes appears to improve the 5-year overall sur-
vival in older patients.8,9
Generally, spindle celletype paratesticular RMS is associated
with a favorable prognosis, with 5-year survival rate of 95%.10
Additionally, lymph node metastasis is less common in the spindle
cell variant comparedwith nonespindle cell variants (16% vs 36%).10
Conclusion
Paratesticular RMS is a very rare tumor with suspicious ﬁndings
on ultrasonographic examination including solid masses with
increasing size and vascularity. Urologists should have a high levelnodules with a rubbery, white-yellow cut surface.
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ential diagnosis. Optimal treatment may be radical orchiectomy
followed by adjuvant chemoradiation. Embryonal spindle celletype
RMS has an overall good prognosis. However, secondary to small
number of cases, randomized prospective data is lacking.References
1. Mak CW, Chou CK, Su CC, et al. Ultrasound diagnosis of paratesticular rhab-
domyosarcoma. Br J Radiol. 2004;77:250e252.
2. Khoubehi B, Mishra V, Ali M, et al. Adult paratesticular tumours. BJU Int.
2002;90:707e715.
3. de Vries JD. Paratesticular rhabdomyosarcoma. World J Urol. 1995;13:219e225.
4. Carroll SJ, Nodit L. Spindle cell rhabdomyosarcoma: a brief diagnostic review
and differential diagnosis. Arch Pathol Lab Med. 2013;137:1155e1158.5. Cavazzana AO, Schmidt D, Ninfo V, et al. Spindle cell rhabdomyosarcoma. A
prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol.
1992;16:229e235.
6. Newton WA Jr, Gehan EA, Webber BL, et alClassiﬁcationof rhabdomyosarcomas
and related sarcomas. Pathologic aspects and proposal for a new classi-
ﬁcationdan Intergroup Rhabdomyosarcoma Study. Cancer. 1995;76:1073e
1085.
7. Hamilton CR, Pinkerton R, Horwich A. The management of paratesticular
rhabdomyosarcoma. Clin Radiol. 1989;40:314e317.
8. Ferrari A, Bisogno G, Casonova M, et al. Paratesticular rhabdomyosarcoma:
report from the Italian and German Cooperative Group. J Clin Oncol. 2002;20:
449e455.
9. Dang ND, Dang PT, Samuelian J, et al. Lymph node management in patients
with paratesticular rhabdomyosarcoma: a population-based analysis. Cancer.
2013;119:3228e3233.
10. Leuschner I, Newton WA Jr, Schmidt D, et alSpindlecell variants of embryonal
rhabdomyosarcoma in the paratesticular region. A report of the Intergroup
Rhabdomyosarcoma Study. Am J Surg Pathol. 1993;17:221e230.
